Matinas Biopharma Holdings, Inc.股价重挫22.71% 市值跌1336.01万美元

自选股智能写手04-03

北京时间2024年04月03日21时31分，Matinas Biopharma Holdings, Inc.（MTNB.us）股票出现异动，股价急速下跌22.71%。截至发稿，该股报0.271美元/股，成交量125.805万股，换手率0.58%，振幅2.29%。最近的财报数据显示，该股实现营业收入1.10百万美元，净利润-22.94百万美元，每股收益-0.11美元，毛利155000.00美元，...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2424846306?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-04-03 21:31","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2424846306","market":"us","top_or_hot":-1,"title":"Matinas Biopharma Holdings, Inc.股价重挫22.71% 市值跌1336.01万美元","media":"自选股智能写手","content":"<div>\n<p>北京时间2024年04月03日21时31分，Matinas Biopharma Holdings, Inc.（MTNB.us）股票出现异动，股价急速下跌22.71%。截至发稿，该股报0.271美元/股，成交量125.805万股，换手率0.58%，振幅2.29%。最近的财报数据显示，该股实现营业收入1.10百万美元，净利润-22.94百万美元，每股收益-0.11美元，毛利155000.00美元，...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404032131438aed9691&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Matinas Biopharma Holdings, Inc.股价重挫22.71% 市值跌1336.01万美元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMatinas Biopharma Holdings, Inc.股价重挫22.71% 市值跌1336.01万美元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-04-03 21:31 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404032131438aed9691&s=b><strong>自选股智能写手</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2024年04月03日21时31分，Matinas Biopharma Holdings, Inc.（MTNB.us）股票出现异动，股价急速下跌22.71%。截至发稿，该股报0.271美元/股，成交量125.805万股，换手率0.58%，振幅2.29%。最近的财报数据显示，该股实现营业收入1.10百万美元，净利润-22.94百万美元，每股收益-0.11美元，毛利155000.00美元，...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404032131438aed9691&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4139","symbol_name":"生物科技","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404032131438aed9691&s=b","article_id":"2424846306","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404032131438aed9691&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2424846306","pubTimestamp":1712151103,"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2024年04月03日21时31分，Matinas Biopharma Holdings, Inc.股票出现异动，股价急速下跌22.71%。Matinas Biopharma Holdings, Inc.股票所在的生物技术行业中，整体跌幅为0.30%。Matinas Biopharma Holdings, Inc.公司简介：Matinas BioPharma Holdings Inc是一家临床阶段的生物制药公司，致力于发现和开发源自其脂质晶体纳米颗粒或耳蜗递送技术平台的候选产品。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK4139":"生物科技","MTNB":"Matinas BioPharma Holdings, Inc"},"translate_title":"Matinas Biopharma Holdings, Inc. shares plunged 22.71% and its market value fell by $13.3601 million","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"MTNB":0.9},"content_text":"北京时间2024年04月03日21时31分，Matinas Biopharma Holdings, Inc.（MTNB.us）股票出现异动，股价急速下跌22.71%。截至发稿，该股报0.271美元/股，成交量125.805万股，换手率0.58%，振幅2.29%。最近的财报数据显示，该股实现营业收入1.10百万美元，净利润-22.94百万美元，每股收益-0.11美元，毛利155000.00美元，市盈率-2.46倍。机构评级方面，在所有2家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。Matinas Biopharma Holdings, Inc.股票所在的生物技术行业中，整体跌幅为0.30%。其相关个股中，Kintara Therapeutics, Inc.、方舟生物医药、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 (To Pur Com)涨幅较大，Kintara Therapeutics, Inc.、方舟生物医药、Addex Therapeutics Limited较为活跃，换手率分别为229.93%、66.14%、16.06%，振幅较大的相关个股有Kintara Therapeutics, Inc.、居里、Pyxis Oncology, Inc.，振幅分别为17.23%、9.09%、8.74%。Matinas Biopharma Holdings, Inc.公司简介：Matinas BioPharma Holdings Inc是一家临床阶段的生物制药公司，致力于发现和开发源自其脂质晶体纳米颗粒或耳蜗递送技术平台的候选产品。 该公司的产品线包括MAT2203，MAT2501等。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":null,"is_publish_news":null,"is_publish_highlight":null,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2424846306"}